Czibere Akos (CIK 2049427) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-24). Recent activity: Buy AKTS (12,500 shares), Sell AKTS (5,099 shares), Sell AKTS (7,401 shares), Buy AKTS (50,000 shares), Sell AKTS (14,800 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | Aktis Oncology, Inc. (AKTS) | Chief Medical Officer | Buy | 12,500 | $61,875 |
| 2026-09-24 | Aktis Oncology, Inc. (AKTS) | Chief Medical Officer | Sell | 5,099 | $102,973 |
| 2026-09-24 | Aktis Oncology, Inc. (AKTS) | Chief Medical Officer | Sell | 7,401 | $155,648 |
| 2026-07-10 | Aktis Oncology, Inc. (AKTS) | Chief Medical Officer | Buy | 50,000 | $247,500 |
| 2026-07-10 | Aktis Oncology, Inc. (AKTS) | Chief Medical Officer | Sell | 14,800 | $401,484 |
| 2026-07-10 | Aktis Oncology, Inc. (AKTS) | Chief Medical Officer | Sell | 30,829 | $861,735 |
| 2026-07-10 | Aktis Oncology, Inc. (AKTS) | Chief Medical Officer | Sell | 4,371 | $125,482 |
来源：SEC Form 4 申报文件 · 截至 2026-09-24